I too am annoyed by the brief period my father spent on Retuxan. For some context, that was administered to him while he was in the acute hospital after his amputation from 8-27 to 11-4. Below is a graph to help illustrate his platelet count vs date with annotations for both his Retuxan and Nplate treatments.
Rituxan to Nplate transition (Imgur)
Unfortunately the LTACH hasn't been as good as furnishing his records and my energy has been focused on navigating the healthcare system for his next steps as opposed to collecting data.
It's difficult to determine the efficacy of Rituxan v. Nplate during this period, but given his recent platelet count has been fluctuating in the 90s to 100s; I think it is reasonable to assume that Nplate is at least keeping his count relatively high.
That said, thank you very much midwest and poseymint for the advice. My father's APS has been described as extremely severe by his hematologist. Within one week he was forming catastrophic clots not just in his legs but organs. So I am -extremely- concerned about clotting and not so much his risk of bleeding. (Frustrating since most of the general physicians and RNs are trained to have the opposite mentality due to the immediate complications of bleeding versus clotting.)
These conditions are all very new to me but I have read about the paradoxical nature of clotting and ITP. To answer your question, b2h, my father hasn't had any major bleeding symptoms. Platelet count aside, the only other symptom of ITP my father was presenting with was petechia in his lower extremities prior to his amputation.
For a bit more context, we have prioritized his conditions for the next two months (from highest to lowest):
1) amputation wounds
2) ITP
3) lymphoma
Because his mobility is severely limited and he still needs to be bladder trained from having a catheter inserted for weeks, maintaining his hygiene is our top concern. His wounds have already recovered from one infection and another one could lead to further operations and restarting the recovery process. (A process already impeded from an altered metabolism due to diabetes.)
To maintain good hygiene, I am negotiating a transfer to a skilled nursing facility (SNF) with an attached nursing home. His Medicare will cover 20 days of SNF care during which I will discuss with their management how to transition him to CNA level nursing home care covered privately. After 60 days of private care, his Medicare should reset and -hopefully- my father will be in a better position to perform more rigorous physical therapy required to regain his independence. (He hasn't been able to do much with a catheter, wound vac hoses and while on morphine every other day following debridement and wound care.)
He can transfer from a hospital bed to a wheelchair and vice versa using a transfer board, but just barely as a fall risk. (And with the bleeding risks associated with low platelets, the staff is reluctant to give him vigorous practice.) So he needs work on that, building upper body strength and core muscles so that he can maneuver better.
While he is receiving care, we can furnish Nplate via CVS Specialty. I am not enamored by this at all due to the high cost (we have yet to officially here what Medicare will and will not cover) and the lack of feedback from his absent hematologist.
But once my father regains mobility and independence we can transition him to receiving injections at his hematologist's infusion center. Fortunately this center is also an oncology clinic and his hematologist is also an oncologist. Unfortunately the hematologist also appears to be stretched very thin. She has been under the impression my father would rebound from the amputation quickly and regain his independence almost instantly and be able to transport himself to her infusion center.
But thank you all for your help and consideration. I appreciate your advice greatly since the medical professionals out here seem to be at a loss for words and almost adversarial due to the perceived liability of these conditions.